Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/2948

TDMS Study 05135-07 Pathology Tables

NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08

                                                         2 YEAR CHRONIC




       Facility:  Battelle Northwest

       Chemical CAS #:  78-79-5

       Lock Date:  03/13/96

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Natural Death                                      5            5            4                                                  
    Moribund Sacrifice                                16           15           18           23                                     
  Survivors                                                                                                                         
    Terminal Sacrifice                                29           30           28           27                                     

  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Small, Ileum                             (49)         (47)         (46)         (50)                                   
      Inflammation, Chronic Active                                               1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      2 (4%)       2 (4%)       3 (6%)       4 (8%)                                
      Basophilic Focus                                36 (72%)     38 (76%)     33 (66%)     33 (66%)                               
      Clear Cell Focus                                 9 (18%)     11 (22%)     10 (20%)     11 (22%)                               
      Degeneration, Cystic                                          1 (2%)                    1 (2%)                                
      Degeneration, Fatty                                           1 (2%)                                                          
      Eosinophilic Focus                               2 (4%)       3 (6%)       1 (2%)       4 (8%)                                
      Fatty Change                                     8 (16%)      6 (12%)     11 (22%)      9 (18%)                               
      Fibrosis                                                                                1 (2%)                                
      Hepatodiaphragmatic Nodule                       2 (4%)       4 (8%)       5 (10%)      6 (12%)                               
      Inflammation, Granulomatous                                                             1 (2%)                                
      Mixed Cell Focus                                 4 (8%)      10 (20%)     10 (20%)      5 (10%)                               
      Necrosis                                                                                1 (2%)                                
      Regeneration                                                  1 (2%)       2 (4%)       3 (6%)                                
      Bile Duct, Cyst                                  1 (2%)       1 (2%)                                                          
      Bile Duct, Hyperplasia                           3 (6%)       9 (18%)      9 (18%)     10 (20%)                               
      Centrilobular, Necrosis                          5 (10%)      5 (10%)      8 (16%)      3 (6%)                                
      Periportal, Infiltration Cellular, Lymphocyte                              1 (2%)                                             
   Mesentery                                          (9)          (10)         (8)          (11)                                   
      Fat, Necrosis                                    9 (100%)    10 (100%)     8 (100%)    11 (100%)                              
   Oral Mucosa                                                     (1)          (1)                                                 
      Pharyngeal, Hyperplasia, Squamous                                          1 (100%)                                           
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Atrophy                                         18 (36%)     13 (26%)     11 (22%)     20 (40%)                               
      Basophilic Focus                                 1 (2%)                    3 (6%)       3 (6%)                                
      Hyperplasia                                                   2 (4%)                                                          
      Metaplasia, Hepatocyte                                        2 (4%)                    1 (2%)                                
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)       1 (2%)                                                          
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Diverticulum                                                  1 (2%)                                                          
      Hyperplasia, Squamous                                                      1 (2%)                                             

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    2                                                              
NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Necrosis                                         5 (10%)      2 (4%)       7 (14%)      3 (6%)                                
   Stomach, Glandular                                 (50)         (49)         (50)         (50)                                   
      Mineralization                                                             1 (2%)                                             
      Necrosis                                         3 (6%)       3 (6%)       4 (8%)       6 (12%)                               
   Tongue                                             (1)                       (2)                                                 
      Hyperplasia                                                                1 (50%)                                            
   Tooth                                                                        (1)          (1)                                    
      Developmental Malformation                                                 1 (100%)     1 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  35 (70%)     33 (66%)     28 (56%)     37 (74%)                               
      Mineralization                                                                          1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Atrophy                                                                                 1 (2%)                                
      Degeneration, Cystic                             1 (2%)                    1 (2%)       3 (6%)                                
      Ectopic Tissue                                                1 (2%)                                                          
      Hyperplasia                                     25 (50%)     17 (34%)     20 (40%)     13 (26%)                               
      Hypertrophy                                      9 (18%)     14 (28%)      8 (16%)     14 (28%)                               
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Necrosis                                         2 (4%)                                 1 (2%)                                
      Thrombosis                                                                              1 (2%)                                
      Vacuolization Cytoplasmic                        4 (8%)       6 (12%)      4 (8%)       6 (12%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                     11 (22%)      6 (12%)      9 (18%)      9 (18%)                               
   Islets, Pancreatic                                 (49)         (50)         (50)         (50)                                   
      Hyperplasia                                      2 (4%)                    1 (2%)       2 (4%)                                
   Parathyroid Gland                                  (48)         (43)         (43)         (45)                                   
      Hyperplasia                                                                1 (2%)                                             
   Pituitary Gland                                    (50)         (50)         (50)         (50)                                   
      Pars Distalis, Hyperplasia                      12 (24%)     16 (32%)      7 (14%)     12 (24%)                               
   Thyroid Gland                                      (48)         (50)         (49)         (50)                                   
      C-Cell, Hyperplasia                             40 (83%)     32 (64%)     38 (78%)     40 (80%)                               
      Follicular Cell, Hyperplasia                     1 (2%)       1 (2%)       1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    3                                                              
NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Clitoral Gland                                     (47)         (48)         (46)         (48)                                   
      Hyperplasia                                      2 (4%)       4 (8%)       2 (4%)       3 (6%)                                
      Inflammation, Chronic Active                                  1 (2%)                                                          
   Ovary                                              (50)         (50)         (50)         (50)                                   
      Cyst                                             5 (10%)      3 (6%)       5 (10%)      6 (12%)                               
      Inflammation, Granulomatous                                   1 (2%)                    2 (4%)                                
   Uterus                                             (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                     1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (49)         (49)         (50)         (50)                                   
      Atrophy                                                                                 1 (2%)                                
      Hyperplasia, Histiocytic                                      1 (2%)                                                          
      Hyperplasia, Reticulum Cell                                   1 (2%)                                                          
      Myelofibrosis                                    1 (2%)                    1 (2%)                                             
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Fibrosis                                         4 (8%)       6 (12%)     10 (20%)      4 (8%)                                
      Hematopoietic Cell Proliferation                 4 (8%)       5 (10%)                   1 (2%)                                
      Hemorrhage                                       1 (2%)       2 (4%)       4 (8%)                                             
      Metaplasia, Osseous                                           1 (2%)                                                          
      Necrosis                                         1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (50)         (50)         (50)         (50)                                   
      Galactocele                                      1 (2%)       1 (2%)       1 (2%)                                             
      Hyperplasia                                      1 (2%)                                 2 (4%)                                
   Skin                                               (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                        1 (2%)                                                                       
      Inflammation, Chronic Active                     1 (2%)       2 (4%)                    2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                           1 (2%)                                                                       
      Hyperostosis                                     6 (12%)      8 (16%)     11 (22%)      8 (16%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    4                                                              
NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Degeneration, Focal                                           1 (2%)                    1 (2%)                                
      Gliosis                                          1 (2%)                                 1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (50)         (50)         (50)         (50)                                   
      Inflammation, Chronic Active                    31 (62%)     29 (58%)     25 (50%)     19 (38%)                               
      Alveolar Epithelium, Hyperplasia                 5 (10%)      5 (10%)     10 (20%)      8 (16%)                               
   Nose                                               (50)         (50)         (50)         (50)                                   
      Foreign Body                                     1 (2%)       1 (2%)       1 (2%)       4 (8%)                                
      Inflammation, Suppurative                        5 (10%)      8 (16%)      8 (16%)     12 (24%)                               
      Thrombosis                                       2 (4%)       2 (4%)       3 (6%)       1 (2%)                                
      Olfactory Epithelium, Atrophy                                 1 (2%)       2 (4%)       2 (4%)                                
      Olfactory Epithelium, Hyperplasia                                          1 (2%)                                             
      Olfactory Epithelium, Metaplasia                 1 (2%)       2 (4%)       1 (2%)       1 (2%)                                
      Respiratory Epithelium, Hyperplasia                           1 (2%)                    1 (2%)                                
      Respiratory Epithelium, Metaplasia, Squamous                  1 (2%)       1 (2%)       1 (2%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (5)          (4)          (3)          (6)                                    
      Cataract                                         5 (100%)     3 (75%)      3 (100%)     4 (67%)                               
      Degeneration                                                  1 (25%)                   1 (17%)                               
      Hemorrhage                                                                              1 (17%)                               
      Retina, Atrophy                                  5 (100%)     2 (50%)      3 (100%)     4 (67%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (49)         (50)         (50)                                   
      Cyst                                             1 (2%)                                 1 (2%)                                
      Hydronephrosis                                                1 (2%)                                                          
      Infarct                                                       1 (2%)       1 (2%)                                             
      Nephropathy                                     46 (92%)     47 (96%)     48 (96%)     47 (94%)                               
      Papilla, Necrosis                                             1 (2%)                                                          
      Renal Tubule, Hyperplasia                        4 (8%)                                                                       
      Renal Tubule, Necrosis                                                                  1 (2%)                                
      Transitional Epithelium, Hyperplasia                                                    1 (2%)                                
   Urinary Bladder                                    (50)         (50)         (50)         (50)                                   

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    5                                                              
NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS FEMALE                   CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Transitional Epithelium, Hyperplasia             1 (2%)                    1 (2%)                                             
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    6                                                              
NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________

DISPOSITION SUMMARY                                                                                                                 

  Animals Initially In Study                          50           50           50           50                                     
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                28           29           30           30                                     
    Natural Death                                      4            5            5            5                                     
  Survivors                                                                                                                         
    Moribund Sacrifice                                                           1                                                  
    Terminal Sacrifice                                18           16           14           15                                     

  Animals Examined Microscopically                    50           50           50           50                                     
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Large, Rectum                            (47)         (49)         (46)         (50)                                   
      Inflammation, Acute                                                        2 (4%)                                             
   Intestine Large, Cecum                             (48)         (47)         (46)         (50)                                   
      Diverticulum                                                               1 (2%)                                             
      Inflammation, Acute                              1 (2%)                                                                       
      Mineralization                                                             1 (2%)                                             
   Intestine Small, Duodenum                          (49)         (49)         (48)         (49)                                   
      Inflammation, Acute                              1 (2%)                    1 (2%)       1 (2%)                                
      Necrosis                                         1 (2%)       1 (2%)       2 (4%)       2 (4%)                                
   Intestine Small, Ileum                             (46)         (47)         (47)         (49)                                   
      Inflammation, Chronic Active                                               1 (2%)                                             
      Necrosis                                                                   1 (2%)                                             
   Liver                                              (50)         (50)         (50)         (50)                                   
      Angiectasis                                      2 (4%)                    5 (10%)      3 (6%)                                
      Basophilic Focus                                17 (34%)     13 (26%)     13 (26%)     16 (32%)                               
      Clear Cell Focus                                 6 (12%)      9 (18%)      7 (14%)      8 (16%)                               
      Degeneration, Cystic                             9 (18%)      9 (18%)     14 (28%)     17 (34%)                               
      Eosinophilic Focus                               2 (4%)       4 (8%)       3 (6%)       3 (6%)                                
      Fatty Change                                    15 (30%)     12 (24%)      9 (18%)     11 (22%)                               
      Hematopoietic Cell Proliferation                 1 (2%)                                 1 (2%)                                
      Hepatodiaphragmatic Nodule                       1 (2%)       1 (2%)       4 (8%)       4 (8%)                                
      Infarct                                                                                 1 (2%)                                
      Inflammation, Acute                                                        1 (2%)                                             
      Inflammation, Chronic Active                                  1 (2%)                                                          
      Inflammation, Granulomatous                                   1 (2%)                                                          
      Mineralization                                   1 (2%)                                                                       
      Mixed Cell Focus                                                                        1 (2%)                                
      Necrosis                                                      1 (2%)       1 (2%)       1 (2%)                                
      Regeneration                                     2 (4%)                    2 (4%)       6 (12%)                               
      Artery, Inflammation, Chronic Active                                                    1 (2%)                                
      Bile Duct, Hyperplasia                          25 (50%)     32 (64%)     36 (72%)     29 (58%)                               
      Centrilobular, Necrosis                          7 (14%)     11 (22%)     10 (20%)      9 (18%)                               
   Mesentery                                          (8)          (12)         (11)         (11)                                   

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    7                                                              
NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ALIMENTARY SYSTEM - CONT                                                                                                            
      Thrombosis                                                                 1 (9%)                                             
      Artery, Mineralization                                                     1 (9%)       2 (18%)                               
      Fat, Hemorrhage                                  1 (13%)      1 (8%)       1 (9%)       1 (9%)                                
      Fat, Inflammation, Chronic Active                                          1 (9%)       1 (9%)                                
      Fat, Necrosis                                    6 (75%)     10 (83%)      8 (73%)      6 (55%)                               
   Oral Mucosa                                        (1)          (1)                                                              
      Pharyngeal, Hyperplasia, Squamous                             1 (100%)                                                        
   Pancreas                                           (50)         (50)         (50)         (50)                                   
      Atrophy                                         18 (36%)     23 (46%)     23 (46%)     15 (30%)                               
      Basophilic Focus                                 1 (2%)       4 (8%)       1 (2%)       3 (6%)                                
      Hyperplasia                                      4 (8%)       6 (12%)      9 (18%)      7 (14%)                               
   Salivary Glands                                    (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)                                                                       
   Stomach, Forestomach                               (50)         (50)         (50)         (50)                                   
      Fibrosis                                                                                1 (2%)                                
      Hyperplasia, Squamous                                         1 (2%)       1 (2%)       1 (2%)                                
      Inflammation, Acute                              1 (2%)                    1 (2%)                                             
      Mineralization                                                             2 (4%)                                             
      Necrosis                                        14 (28%)      8 (16%)     10 (20%)     12 (24%)                               
   Stomach, Glandular                                 (50)         (50)         (50)         (50)                                   
      Mineralization                                   5 (10%)      1 (2%)       4 (8%)       4 (8%)                                
      Necrosis                                         6 (12%)      3 (6%)       7 (14%)      9 (18%)                               
   Tongue                                                                       (1)          (1)                                    
      Hyperplasia                                                                1 (100%)                                           
   Tooth                                                           (1)                                                              
      Developmental Malformation                                    1 (100%)                                                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Blood Vessel                                       (1)                       (2)          (3)                                    
      Inflammation                                     1 (100%)                                                                     
      Aorta, Mineralization                                                      2 (100%)     3 (100%)                              
      Endothelium, Hyperplasia                         1 (100%)                                                                     
   Heart                                              (50)         (50)         (50)         (50)                                   
      Cardiomyopathy                                  41 (82%)     44 (88%)     44 (88%)     38 (76%)                               
      Artery, Mineralization                           1 (2%)                    2 (4%)       4 (8%)                                
      Atrium, Thrombosis                               4 (8%)       3 (6%)       3 (6%)       5 (10%)                               
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Adrenal Cortex                                     (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)                                 1 (2%)                                
      Degeneration, Cystic                                                                    1 (2%)                                
      Hyperplasia                                     23 (46%)     23 (46%)     19 (38%)     20 (40%)                               
      Hypertrophy                                      8 (16%)     11 (22%)      4 (8%)       4 (8%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    8                                                              
NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
ENDOCRINE SYSTEM - CONT                                                                                                             
      Necrosis                                                                   1 (2%)                                             
      Thrombosis                                                                              1 (2%)                                
      Vacuolization Cytoplasmic                        2 (4%)       6 (12%)      3 (6%)       6 (12%)                               
   Adrenal Medulla                                    (50)         (50)         (50)         (50)                                   
      Angiectasis                                                   1 (2%)                                                          
      Hyperplasia                                     19 (38%)     19 (38%)     25 (50%)     21 (42%)                               
      Thrombosis                                                                              1 (2%)                                
      Bilateral, Hyperplasia                                                     2 (4%)                                             
   Islets, Pancreatic                                 (50)         (50)         (50)         (49)                                   
      Hyperplasia                                                   1 (2%)       3 (6%)                                             
   Parathyroid Gland                                  (48)         (46)         (45)         (47)                                   
      Cyst                                                          1 (2%)                                                          
      Hyperplasia                                      5 (10%)      6 (13%)      8 (18%)     13 (28%)                               
   Pituitary Gland                                    (50)         (50)         (50)         (49)                                   
      Pars Distalis, Hyperplasia                       5 (10%)      6 (12%)      9 (18%)     11 (22%)                               
      Pars Intermedia, Hyperplasia                                                            1 (2%)                                
   Thyroid Gland                                      (49)         (50)         (49)         (50)                                   
      C-Cell, Hyperplasia                             30 (61%)     30 (60%)     30 (61%)     34 (68%)                               
      Follicular Cell, Hyperplasia                     1 (2%)       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (50)         (50)         (50)         (50)                                   
      Granuloma Sperm                                  1 (2%)                    1 (2%)                                             
   Preputial Gland                                    (50)         (50)         (50)         (50)                                   
      Hyperplasia                                                   1 (2%)                    1 (2%)                                
      Inflammation, Chronic Active                     3 (6%)       1 (2%)       1 (2%)       3 (6%)                                
   Prostate                                           (50)         (50)         (50)         (50)                                   
      Hyperplasia                                     11 (22%)     13 (26%)     15 (30%)     17 (34%)                               
      Inflammation, Chronic Active                     5 (10%)      2 (4%)       1 (2%)       6 (12%)                               
   Seminal Vesicle                                    (47)         (48)         (47)         (50)                                   
      Inflammation, Chronic Active                     1 (2%)                                                                       
   Testes                                             (50)         (50)         (50)         (50)                                   
      Atrophy                                          1 (2%)       1 (2%)       1 (2%)                                             
      Artery, Inflammation, Chronic Active             6 (12%)      2 (4%)       1 (2%)                                             
      Interstitial Cell, Hyperplasia                  15 (30%)     13 (26%)      8 (16%)                                            
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page    9                                                              
NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (50)         (50)         (49)         (50)                                   
      Hyperplasia, Histiocytic                                      1 (2%)                                                          
      Myelofibrosis                                                                           1 (2%)                                
      Necrosis                                                                                2 (4%)                                
   Lymph Node                                         (6)          (7)          (7)          (9)                                    
      Iliac, Ectasia                                   1 (17%)                                                                      
      Renal, Hemorrhage                                                                       1 (11%)                               
   Lymph Node, Mandibular                             (49)         (46)         (46)         (44)                                   
      Infiltration Cellular, Plasma Cell                            2 (4%)                                                          
   Lymph Node, Mesenteric                             (50)         (49)         (49)         (50)                                   
      Infiltration Cellular, Plasma Cell                                                      1 (2%)                                
   Spleen                                             (50)         (50)         (50)         (50)                                   
      Depletion Cellular                                                                      1 (2%)                                
      Fibrosis                                        11 (22%)     14 (28%)     24 (48%)     22 (44%)                               
      Hematopoietic Cell Proliferation                 3 (6%)       3 (6%)       1 (2%)       5 (10%)                               
      Hemorrhage                                       1 (2%)                                                                       
      Necrosis                                         3 (6%)                    2 (4%)       1 (2%)                                
   Thymus                                             (47)         (44)         (49)         (47)                                   
      Atrophy                                                                                 1 (2%)                                
      Cyst                                             1 (2%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (42)         (43)         (47)         (44)                                   
      Galactocele                                      2 (5%)       4 (9%)       2 (4%)       3 (7%)                                
      Inflammation, Chronic                            1 (2%)                                                                       
   Skin                                               (50)         (50)         (50)         (50)                                   
      Cyst Epithelial Inclusion                        2 (4%)                                 2 (4%)                                
      Inflammation, Chronic Active                                  1 (2%)       2 (4%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (50)         (50)         (50)         (50)                                   
      Fibrous Osteodystrophy                           2 (4%)       1 (2%)       6 (12%)      7 (14%)                               
      Hyperostosis                                                  1 (2%)       1 (2%)       2 (4%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   Brain                                              (50)         (50)         (50)         (50)                                   
      Degeneration, Focal                              1 (2%)                                                                       
      Gliosis                                                       1 (2%)                                                          
____________________________________________________________________________________________________________________________________
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   10                                                              
NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (49)         (50)         (50)         (50)                                   
      Inflammation, Chronic, Focal                                  1 (2%)                                                          
      Inflammation, Chronic Active                    21 (43%)     16 (32%)     22 (44%)     15 (30%)                               
      Mineralization                                                             2 (4%)       2 (4%)                                
      Thrombosis                                                    1 (2%)                    1 (2%)                                
      Alveolar Epithelium, Hyperplasia                 7 (14%)     11 (22%)      4 (8%)      10 (20%)                               
      Artery, Mediastinum, Mineralization                                        2 (4%)       2 (4%)                                
   Nose                                               (50)         (50)         (49)         (50)                                   
      Foreign Body                                     4 (8%)       4 (8%)       3 (6%)       2 (4%)                                
      Inflammation, Suppurative                       11 (22%)      9 (18%)     10 (20%)      9 (18%)                               
      Thrombosis                                       2 (4%)       4 (8%)      10 (20%)      5 (10%)                               
      Olfactory Epithelium, Atrophy                    1 (2%)                    8 (16%)      2 (4%)                                
      Olfactory Epithelium, Metaplasia                 7 (14%)      2 (4%)       1 (2%)       2 (4%)                                
      Olfactory Epithelium, Metaplasia, Squamous       1 (2%)                                                                       
      Respiratory Epithelium, Hyperplasia                           2 (4%)       2 (4%)       2 (4%)                                
      Respiratory Epithelium, Metaplasia, Squamous                               1 (2%)                                             
   Trachea                                            (50)         (50)         (50)         (50)                                   
      Mineralization                                                             1 (2%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   Eye                                                (1)          (3)          (3)          (2)                                    
      Cataract                                         1 (100%)     1 (33%)      3 (100%)     2 (100%)                              
      Hemorrhage                                                                 1 (33%)                                            
      Cornea, Inflammation, Chronic Active                          1 (33%)      1 (33%)                                            
      Retina, Atrophy                                  1 (100%)     2 (67%)      3 (100%)     2 (100%)                              
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (50)         (50)         (50)         (50)                                   
      Cyst                                             2 (4%)                    4 (8%)       2 (4%)                                
      Infarct                                          1 (2%)       1 (2%)       2 (4%)                                             
      Mineralization                                                             2 (4%)       3 (6%)                                
      Nephropathy                                     50 (100%)    50 (100%)    50 (100%)    49 (98%)                               
      Renal Tubule, Hyperplasia                                     2 (4%)       6 (12%)      8 (16%)                               
   Urinary Bladder                                    (50)         (49)         (50)         (50)                                   
      Hemorrhage                                                                              1 (2%)                                
      Inflammation, Acute                                                                     1 (2%)                                
      Inflammation, Chronic Active                     1 (2%)                                 1 (2%)                                
      Necrosis                                                                                1 (2%)                                

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   11                                                              
NTP Experiment-Test: 05135-07         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: CHRONIC                                              ISOPRENE                                         Date: 09/24/97  
Route: RESPIRATORY EXPOSURE WHOLE BODY                                                                            Time: 09:49:08  
____________________________________________________________________________________________________________________________________

         FISCHER 344 RATS MALE                     CONTROL      220 PPM      700 PPM      7000 PPM                                  
                                                                                                                                    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
URINARY SYSTEM - CONT                                                                                                               
      Transitional Epithelium, Hyperplasia             1 (2%)                                                                       
                                                                                                                                    

a  Number of animals examined microscopically at site and number of animals with lesion                                             

                                                             Page   12                                                              
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------